Tokyo Joe's Cafe / Societe Anonyme/No Pennies Message Board

STOCKTALK

We've detected that you're using an ad content blocking browser plug-in or feature. Ads provide a critical source of revenue to the continued operation of Silicon Investor. We ask that you disable ad blocking while on Silicon Investor in the best interests of our community. If you are not using an ad blocker but are still receiving this message, make sure your browser's tracking protection is set to the 'standard' level.

Microcap & Penny Stocks : Tokyo Joe's Cafe / Societe Anonyme/No Pennies

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next

To: DO$Kapital who wrote (25147)	12/9/1998 8:50:00 PM
From: hoffy	Read Replies (2) of 119973

>>>><<<Aastrom Biosciences Presents Clinical Results at The American Society of Hematology Meeting MIAMI, Dec. 7 /PRNewswire/ -- Multi-center clinical trial results presented at the annual scientific meeting of the American Society of Hematology (ASH) have provided further evidence of the safety and clinical utility of the AastromReplicell(TM) Cell Production System (System) for stem cell transplantation, according to Aastrom Biosciences, Inc. (Nasdaq: ASTM). Results from four clinical studies conducted at multiple sites will be used to support European marketing efforts to begin later this year, and to establish the use of the AastromReplicell(TM) System for production of bone marrow and cord blood cells for transplantation. <<<<< I wish ASTM would have put this out tonight. They should get a similar release out tonight or tomorrow before the bell so this technology is known as theirs.

Report TOU Violation

Share This Post

Public Reply Prvt Reply Mark as Last Read File

Previous 10 Next 10 Previous Next